- ￥1600 - 2800
- Sino Biological
- 北京
- 40203-VNAHC
- 2025年08月12日
企业认证
相关产品推荐更多 >
重组蛋白|Recombinant Coxsackievirus (CV) A6 VP1 Protein (His Tag)
￥4520
Influenza A H5N1 (A/Japanese white-eye/Hong Kong/1038/2006) Hemagglutinin Protein (HA1 Subunit) (His Tag)
￥4520
Recombinant H7N9 (A/Anhui/1/2013) HA Protein (His Tag) | 重组甲型流感 H7N9 (A/Anhui/1/2013)
￥4520Influenza A H6N2 (A/duck/Shantou/83/2000) Hemagglutinin / HA Protein (His Tag)
￥4520
SARS-CoV-2 (2019-nCoV) Spike RBD(P384L)-His重组蛋白
￥4500
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件：
-20℃ 至 -80℃
- 保质期：
12个月
- 英文名：
Influenza B (B/Brisbane/60/2008) Neuraminidase / NA (Active)
- 库存：
99
- 供应商：
北京义翘神州科技股份有限公司
- 规格：
100 U/1000 U
| 规格： | 100 U | 产品价格： | ￥1600.0 |
|---|---|---|---|
| 规格： | 1000 U | 产品价格： | ￥2800.0 |
蛋白名称：Neuraminidase/NA蛋白, Neuraminidase/NA protein
蛋白构建：A DNA sequence encoding Influenza B (B/Brisbane/60/2008) Neuraminidase (4CPL_A) (Met1-Leu466), termed as NA, was expressed.
表达宿主：HEK293 Cells
蛋白纯度：0
蛋白活性：Measured by its ability to cleave a fluorogenic substrate, 2'-(4-Methylumbelliferyl)-α-D-N-acetylneuraminic acid. The specific activity is > 100 U. The specific activity is > 1000 U.
蛋白内毒素：< 1.0 EU per μg protein as determined by the LAL method.
预测N端：0
蛋白分子量：The recombinant influenza B (B/Brisbane/60/2008) Neuraminidase consists of 466 amino acids and predicts a molecular mass of 51.1 kDa.
蛋白NP号：4CPL_A
蛋白氨基酸序列：Met1-Leu466
蛋白标签：Native
蛋白保存条件：Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Neuraminidase inhibitors (NAIs) are presently the only effective antiviral drugs for treatment and chemoprophylaxis of influenza A and B infections, due to the high prevalence of resistance to the adamantane class of drugs among influenza
PCR for the Detection of Influenza Viruses in Clinical Material
). Influenza A viruses are further divided into subtypes H1N1, H2N2 and H3N2, based on differences in the hemagglutinin (HA) and neuraminidase (NA) genes. The ability of influenza viruses to undergo antigenic change in HA and NA enables the virus to evade
Genetic Engineering of Live Attenuated Influenza Viruses
vaccine strain is a reassortant virus that contains the hemagglutinin (HA) and neuraminidase (NA) gene segments from a wild-type influenza virus and the six internal protein gene segments from a master donor virus (MDV) of either cold-adapted A/Ann Arbor
技术资料暂无技术资料 索取技术资料
